Article

HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG

2022-09-23

Abstract excerpt

<h4>Background</h4> HeberFERON is a co-formulation of α2b and γ interferons, based on their synergism, that have shown its clinical superiority over individual interferons in basal cell carcinomas. In Glioblastoma (GBM), HeberFERON has shown promising preclinical and clinical results. This motivated us to design a microarray experiment aimed to identify the molecular mechanisms involved into the distinctive effec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb43f881-70c2-55be-a0ba-ebd6ef86a8a3
DOI: 10.1101/2022.09.22.508971

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MGDOI 10.1101/2022.09.22.508971Read

A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MGSemantic proximity Read

Proteomics and phosphoproteomics profiling of the co-formulation of type I and II interferons, HeberFERON, in the glioblastoma-derived cell line U-87 MGSemantic proximity Read

TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanismsSemantic proximity Read

Mitotic Poisons In Cancer PharmacotherapySemantic proximity Read

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma linesSemantic proximity Read

From Undruggable to Therapeutic: Housekeeping Gene Expression Patterns in Human Peripheral Blood Mononuclear Cells Treated with MetadicholSemantic proximity Read

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastomaSemantic proximity Read

Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture modelsSemantic proximity Read

Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cellsSemantic proximity Read

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastomaSemantic proximity Read

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell linesSemantic proximity Read

Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics.Semantic proximity Read